GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 707 filers reported holding GLAXOSMITHKLINE PLC in Q1 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,000 | -90.9% | 47 | -90.9% | 0.00% | -85.7% |
| Q2 2016 | $22,000 | +57.1% | 514 | +48.1% | 0.01% | +40.0% |
| Q1 2016 | $14,000 | -53.3% | 347 | -53.5% | 0.01% | -44.4% |
| Q4 2015 | $30,000 | +3.4% | 747 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $29,000 | -6.5% | 747 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $31,000 | -8.8% | 747 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $34,000 | +13.3% | 747 | +6.7% | 0.01% | +12.5% |
| Q4 2014 | $30,000 | -64.7% | 700 | -62.3% | 0.01% | -65.2% |
| Q3 2014 | $85,000 | -24.8% | 1,859 | -12.2% | 0.02% | -25.8% |
| Q2 2014 | $113,000 | -16.3% | 2,117 | -16.4% | 0.03% | -18.4% |
| Q1 2014 | $135,000 | 0.0% | 2,533 | 0.0% | 0.04% | -2.6% |
| Q4 2013 | $135,000 | +0.7% | 2,533 | -5.0% | 0.04% | -13.3% |
| Q3 2013 | $134,000 | -56.2% | 2,665 | -56.5% | 0.04% | -16.7% |
| Q2 2013 | $306,000 | – | 6,130 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |